GLP-1 drugs

3 statements across 1 episodes · 1 bullish · 2 bearish · 1 people on the record · first statement Jan 22, 2024 by Ben Gilbert · across every show →

Everything said about GLP-1 drugs, oldest first

Jan 22, 2024 negative
Assertion Supported
Research shows up to 68% of patients discontinue GLP-1s after a year
“There's some research that points out that as many as 68% of people roll off it after a year, and part of this is related to price, or changing insurance that doesn't cover it, or that it's hard to find since they're still supply constrained, or maybe there ar…”
Ben Gilbert Jan 22, 2024 ▶ 2:39:10 Novo Nordisk (Ozempic) · Acquired
Jan 22, 2024 bearish
Assertion Supported
Early studies show GLP-1 weight loss causes 40% lean muscle loss
“When you're losing weight normally, you lose, like, 25% lean muscle, and these early studies are showing it's something like 40%.”
Ben Gilbert Jan 22, 2024 ▶ 3:36:01 Novo Nordisk (Ozempic) · Acquired
Jan 22, 2024 bullish
Prediction Not checkable as stated
GLP-1s could surpass Humira and remain defensible for a decade
“So I think, assuming that Novo stays sort of neck and neck with Eli Lilly as they both keep coming out with better and better versions, that this could be the next Humira, or potentially much bigger than Humira. And I think the defensibility is an open questio…”
Ben Gilbert Jan 22, 2024 ▶ 3:35:25 Novo Nordisk (Ozempic) · Acquired
Made with StarZero

Turn any episode into a week of clips.

This entire site, nearly 80 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.